Format

Send to

Choose Destination
Mol Immunol. 2020 Feb;118:110-116. doi: 10.1016/j.molimm.2019.12.010. Epub 2019 Dec 20.

Single-domain antibodies for functional targeting of the signaling scaffold Shoc2.

Author information

1
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, United States.
2
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, United States. Electronic address: emilia.galperin@uky.edu.

Abstract

The accurate transmission of signals by the canonical ERK1/2 kinase pathway critically relies on the proper assembly of an intricate multiprotein complex by the scaffold protein Shoc2. However, the details of the mechanism by which Shoc2 guides ERK1/2 signals are not clear, in part, due to the lack of research tools targeting specific protein binding moieties of Shoc2. We report generation and characterization of single domain antibodies against human Shoc2 using a universal synthetic library of humanized nanobodies. Our results identify eight synthetic single-domain antibodies and show that two evaluated antibodies have binding affinities to Shoc2 in the nanomolar range. High affinity antibodies were uniquely suited for the analysis of the Shoc2 complex assembly. Selected single-domain antibodies were also functional in intracellular assays. This study illustrates that Shoc2 single-domain antibodies can be used to understand functional mechanisms governing complex multiprotein signaling modules and have promise in application for therapies that require modulation of the ERK1/2-associated diseases.

KEYWORDS:

ERK1/2 signaling; Scaffold; Shoc2; Single domain antibody

PMID:
31869742
PMCID:
PMC6981032
[Available on 2021-02-01]
DOI:
10.1016/j.molimm.2019.12.010

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center